In addition, IL-6 signaling and JAK/STAT signaling were enriched in the high ADAR1 group, suggesting that inflammatory cytokine signaling may further enhance ADAR1 expression in high-risk MM (Supplementary Fig. 2d, e). Here, IL6 is linked to Miyoshi myopathy.